[PDF] Top 20 Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer

... particularly in tumor cells. In breast cancer cells with high proliferative activity, the concentration of the key enzyme TP is essentially higher than in other tissues, and even ... See full document

... frequently in the lapatinib plus capecitabine arm, and thrombo- cytopenia and elevated transaminases occurred to a greater extent in the T-DM1 ...occurred in the first two cycles of treat- ... See full document

... 863 patients with metastatic disease at either ini- tial diagnosis or recurrence after receiving adjuvant therapy between January 2000 and Decem- ber ...the breast cancer ... See full document

... HRþ breast cancer when NET is considered. This is also true both in the adjuvant and metastatic settings, based on several clinical trials that demonstrated their superiority over ...issue ... See full document

... changes in older patients, or those with higher Gleason scores, higher PSA levels or higher SUVmax ...values. Patients with lower SUV- max values were notably younger and ... See full document

... modality in the management of patients with recurrent and metastatic cervical cancer, its effectiveness is relative poor comparing to other gynecologic ...operation or ... See full document

... against cancer targets the several phases of the cell cycle, thereby interfering in cell growth and division and leading to cell ...directly or indirectly on the synthesis and replication of DNA, for ... See full document

... change in the number of ...single-fraction or multiple-fraction radiotherapy: it can be speculated that countries with fewer outpatient visits and procedures may use single-fraction radiotherapy more ... See full document

... for breast cancer in the context of evidence-based ...for breast cancer. The search was performed in the MEDLINE, Scopus, PEDro and LILACS databases using the terms axillary web ... See full document

... initiated in 1984 in patients with intermediate risk bladder ...publication with roughly 20 years of overall follow-up focuses on the durability of the response and the possible impact ... See full document

... correlate with radiographic determinations of disease progression, but also to be more accurate and reproducible, having an inter-reader variability of 1% versus 15%, a short half-life ...associated with ... See full document

... chemohormonal therapy in patients with metastatic hormone-sensitive and non- metastatic high-risk prostate ...chemohormonal therapy versus androgen deprivation ... See full document

... rate. In animal models of anthracyclines toxicity, doxorubicin was proven to consistently induce a reduction in resting heart rate, reflective of damage of the sinoatrial node ...treatment with ... See full document

... conventional฀ therapy฀ were฀ studied,฀ after฀ their฀ informed฀ consent฀ had฀ been฀ ...Thirty-one฀ patients฀ had฀ prostate฀ cancer,฀ twenty฀ had฀ breast฀ cancer,฀ three฀ had฀ lung฀ ... See full document

... engineered in R- LM249 genome to monitor intraperitoneal viral spread and to image the ...tumors. In this instance, R-LM249 was ...replicated in all visible intraperitoneal tumor masses, producing a ... See full document

... der in Deutschland durch die AUO initiierten G-RAMPP-Studie – ein randomisierter 1:1-Vergleich von An- drogendeprivation alleine mit radikaler Prostatektomie + An- drogendeprivation – verspricht man sich Antwort ... See full document

... by breast cancer immunophenotypical sybtypes as shown in Table ...found in over 80% of luminal-HER2, HER2-enriched, TNBC and BCP tumors ...respectively). In this cohort with ... See full document

... breast cancer were assigned to receive tamoxifen 20 mg/day or ...diagnosed with breast cancer found that the use of tamoxifen was not associated with a reduced risk of ... See full document

... Grup terapisi bireysel terapiden farklı olarak üç avantaj sunmaktadır.[39] Bunlardan ilki grup terapisi sırasındaki üyelerden alınan sosyal destektir. Bir grubun üyesi olmak kan- ser hastalığı ile başa çıkma sürecinde ... See full document

... pathological or immunohistochemical factors may be predictive of metastatic involvement of other lymph nodes in patients with breast carcinoma undergoing sentinel lymph node ... See full document